Unplanned 30-Day Readmission after Coronary Artery Bypass in Patients with Acute Myocardial Infarction
Related Experiment Video
Updated: Jan 20, 2026

Left Coronary Artery Ligation: A Surgical Murine Model of Myocardial Infarction
Published on: August 9, 2022
Robert Case1, Jerin George1, Qian Li2
1Department of Medicine, University of Florida, Gainesville, FL, United States of America.
Insights
Nearly a quarter of patients undergoing coronary artery bypass graft surgery (CABG) after a heart attack (MI) face unplanned readmission within 30 days. Female sex, early CABG post-MI, and post-operative atrial fibrillation predict readmission risk.
Area of Science:
- Cardiology
- Cardiovascular Surgery
- Health Services Research
Background:
- Hospitals face penalties for high readmission rates after coronary artery bypass graft surgery (CABG).
- Limited data exists on outcomes for patients with acute myocardial infarction (MI) who undergo CABG as their primary revascularization method.
Purpose of the Study:
- To determine the 30-day unplanned readmission rate in high-risk patients who had an acute MI and underwent CABG.
- To identify predictors of unplanned readmission in this patient population.
Main Methods:
- An institutional database was queried for patients admitted with acute MI who underwent CABG within 30 days (2011-2017).
- Chart review was conducted to gather demographic, comorbidity, and clinical data, including readmission status.
Main Results:
- The 30-day unplanned readmission rate was 23% among 150 included patients.
- The majority of readmissions (80%) were non-cardiac related.
- Predictors of readmission included female sex (OR 2.61), CABG performed <7 days post-MI (OR 2.82), and post-operative atrial fibrillation (OR 3.25).
Conclusions:
- Patients undergoing CABG post-MI represent a high-risk group with a significant readmission rate.
- Female sex, early CABG after MI, and post-operative atrial fibrillation are key predictors for readmission.
- Early outpatient follow-up may reduce readmissions by addressing patient concerns about post-operative symptoms.
Background/Purpose:
The Centers for Medicare and Medicaid services penalizes hospitals with higher than expected readmissions for coronary artery bypass graft surgery (CABG). Little information exists regarding outcomes in patients who sustain an acute myocardial infarction (MI) and undergo CABG as the primary revascularization strategy. Our goal was to determine the unplanned 30-day readmission rate in this high-risk population and predictors of readmission.
Materials/Methods:
An institutional database was queried to identify patients from 2011 to 2017 who were admitted with an acute MI and underwent CABG within 30 days. Chart review was performed to collect demographics, medical comorbidities and clinical information related to hospital course and readmission status.
Results:
A total of 150 patients were included. The 30-day unplanned readmission rate was 23%, and the majority (80%) were non-cardiac related. Predictors of unplanned readmission included female sex (OR 2.61, 95% CI 1.042-6.549, p = 0.041), CABG performed <7 days following MI (OR 2.82, 95% CI 1.21-6.59, p = 0.017), and post-operative atrial fibrillation (OR 3.25, 95% CI 1.07-9.87, p = 0.038). Complications were identified in 32% of clinic visits in patients who did not require readmission.
Conclusions:
Patients who undergo CABG following MI are a high-risk population with nearly one-quarter readmitted within 30 days. Female sex, <7 days between the index MI and CABG, and post-operative atrial fibrillation are strong predictors for readmission. Early outpatient follow-up may be an effective intervention to reduce hospital readmissions by reassuring patients that non-cardiac symptoms are in line with anticipated post-operative pain and healing.
Related Concept Videos
Acute Coronary Syndrome I: Introduction
Coronary Artery Disease I: Introduction
Coronary Artery Disease II: Pathophysiology
Acute Coronary Syndrome V: Nursing Management
Coronary Artery Disease V: Interprofessional Care
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

